Cargando…

Ilixadencel – an Allogeneic Cell-Based Anticancer Immune Primer for Intratumoral Administration

Intratumoral administration of an immune primer is a therapeutic vaccine strategy aimed to trigger dendritic cell (DC)-mediated cross-presentation of cell-associated tumor antigens to cytotoxic CD8(+) T cells without the need for tumor antigen characterization. The prevailing view is that these cros...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karlsson-Parra, Alex, Kovacka, Juliana, Heimann, Emilia, Jorvid, Margareth, Zeilemaker, Sijme, Longhurst, Sharon, Suenaert, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2018
Materias:	Expert Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002422/ https://www.ncbi.nlm.nih.gov/pubmed/29904904 http://dx.doi.org/10.1007/s11095-018-2438-x

Ejemplares similares

Phase I trial evaluating safety and efficacy of intratumorally administered inflammatory allogeneic dendritic cells (ilixadencel) in advanced gastrointestinal stromal tumors
por: Fröbom, Robin, et al.
Publicado: (2020)

Phase 1 Trial With the Cell-Based Immune Primer Ilixadencel, Alone, and Combined With Sorafenib, in Advanced Hepatocellular Carcinoma
por: Rizell, Magnus, et al.
Publicado: (2019)

Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study
por: Lindskog, Magnus, et al.
Publicado: (2022)

Long-term survival in unfavourable-risk mRCC patients after intratumoral administration of a cell-based allogeneic vaccine
por: Karlsson-Parra, Alex, et al.
Publicado: (2015)

Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release
por: Oerlemans, Chris, et al.
Publicado: (2010)

Enhancing anticancer effects, decreasing risks and solving practical problems facing 3-bromopyruvate in clinical oncology: 10 years of research experience
por: El Sayed, Salah Mohamed
Publicado: (2018)

Intratumoral administration of pro-inflammatory allogeneic dendritic cells improved the anti-tumor response of systemic anti-CTLA-4 treatment via unleashing a T cell-dependent response
por: Jin, Chuan, et al.
Publicado: (2022)

Towards the elimination of cervical cancer in Japan
por: Hanley, Sharon J.B.
Publicado: (2021)

Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapy
por: Kim, Jeongrae, et al.
Publicado: (2023)

Delivery Systems and Local Administration Routes for Therapeutic siRNA
por: Vicentini, Fabiana Testa Moura de Carvalho, et al.
Publicado: (2013)

Dysplasia of the fibrous sheath with axonemal and centriolar defects combined with lack of mitochondrial activity as associated factors of ICSI failure in primary ciliary dyskinesia syndrome
por: Pariz, Juliana R., et al.
Publicado: (2020)

Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinoma
por: Laurell, Anna, et al.
Publicado: (2017)

Is physician supervision of the capsaicin 8% patch administration procedure really necessary? An opinion from health care professionals
por: Kern, Kai-Uwe, et al.
Publicado: (2013)

Genetically encoded sensors enable micro- and nano-scopic decoding of transmission in healthy and diseased brains
por: Lin, Li, et al.
Publicado: (2020)

Recommendations and Guidance for Steroid Injection Therapy and COVID-19 Vaccine Administration from the American Society of Pain and Neuroscience (ASPN)
por: Chakravarthy, Krishnan, et al.
Publicado: (2021)

Discovery of Intratumoral Oncolytic Bacteria Toward Targeted Anticancer Theranostics
por: Goto, Yamato, et al.
Publicado: (2023)

Military-related mild traumatic brain injury: clinical characteristics, advanced neuroimaging, and molecular mechanisms
por: Kim, Sharon Y., et al.
Publicado: (2023)

Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?
por: Cazzaniga, Marina Elena, et al.
Publicado: (2019)

Intratumoral TNFα improves immunotherapy
por: Johansson, Anna, et al.
Publicado: (2012)

Molecular Studies in Treponema pallidum Evolution: Toward Clarity?
por: Mulligan, Connie J., et al.
Publicado: (2008)

Matrix Metalloproteinase Gene Delivery for Liver Fibrosis
por: Iimuro, Yuji, et al.
Publicado: (2007)

First Isolation of Mycobacterium ulcerans from an Aquatic Environment: The End of a 60-Year Search?
por: Stinear, Tim, et al.
Publicado: (2008)

Schistosomiasis Japonica: The DALYs Recaptured
por: King, Charles H.
Publicado: (2008)

The Schistosomiasis Research Agenda—What Now?
por: Bethony, Jeffrey M., et al.
Publicado: (2008)

Designer Gene Delivery Vectors: Molecular Engineering and Evolution of Adeno-Associated Viral Vectors for Enhanced Gene Transfer
por: Kwon, Inchan, et al.
Publicado: (2007)

Natural and Synthetic Polymers as Inhibitors of Drug Efflux Pumps
por: Werle, Martin
Publicado: (2007)

Toward Comprehensive Interventions to Improve the Health of Women of Reproductive Age
por: Friedman, Jennifer F., et al.
Publicado: (2008)

Reports on the Prevalence of Clinical Conditions Are More Convincing When Supported by Objective Evidence
por: Schachter, Julius, et al.
Publicado: (2008)

Cancer is a Preventable Disease that Requires Major Lifestyle Changes
por: Anand, Preetha, et al.
Publicado: (2008)

Preparation of Active Proteins, Vaccines and Pharmaceuticals as Fine Powders using Supercritical or Near-Critical Fluids
por: Cape, Stephen P., et al.
Publicado: (2008)

Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents
por: Canitano, Roberto, et al.
Publicado: (2008)

Tiagabine: efficacy and safety in partial seizures – current status
por: Bauer, Jürgen, et al.
Publicado: (2008)

Tracking the Odysseys of Juvenile Schistosomes to Understand Host Interactions
por: Jones, Malcolm K., et al.
Publicado: (2008)

On The Rate and Extent of Drug Delivery to the Brain
por: Hammarlund-Udenaes, Margareta, et al.
Publicado: (2007)

Discovery and Development of Toll-Like Receptor 4 (TLR4) Antagonists: A New Paradigm for Treating Sepsis and Other Diseases
por: Leon, Carlos G., et al.
Publicado: (2008)

Extrinsic Fluorescent Dyes as Tools for Protein Characterization
por: Hawe, Andrea, et al.
Publicado: (2008)

Intravesical Treatments of Bladder Cancer: Review
por: Shen, Zancong, et al.
Publicado: (2008)

The Apoptosome: Emerging Insights and New Potential Targets for Drug Design
por: D’Amelio, Marcello, et al.
Publicado: (2007)

Immune Cell Recruitment and Cell-Based System for Cancer Therapy
por: Gao, Jian-Qing, et al.
Publicado: (2007)

Expert Canadian consensus suggestions on the rational, clinical use of ziprasidone in the treatment of schizophrenia and related psychotic disorders
por: Kutcher, Stan, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_nfichodi4pcbo2pcaojurp2iah